Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Chanson

Showing results (161-170 of 363) with videos related to

Pageof 37
Sort By:
Journal of the Endocrine Society|August 7, 2024
Increase in Testosterone Levels and Improvement of Clinical Symptoms in Eugonadic men With a Prolactin-secreting AdenomaLea Carlier, Philippe Chanson, Laure Cazabat, et al.
Endocrine|November 7, 2018
Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literatureClaire Briet, Mirela Diana Ilie, Emmanuelle Kuhn, et al.
Pituitary|July 25, 2019
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation studyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Lancet (London, England)|October 28, 2023
Growing heart in congenital hypopituitarism treated in adulthoodYves Fromes, Fanny Chasseloup, Claire Bouvattier, et al.
Endocrine|April 14, 2021
Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomasOrsalia Alexopoulou, Valérie Everard, Martine Etoa, et al.
European Journal of Endocrinology|December 10, 2016
Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysisNicholas A Tritos, Philippe Chanson, Camilo Jimenez, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegalyLuigi Maione, Cyril Garcia, Amir Bouchachi, et al.
Frontiers in Endocrinology|December 18, 2018
Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome InstabilityAnne Wierinckx, Etienne Delgrange, Philippe Bertolino, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2021
International Multicenter Validation Study of the SAGIT® Instrument in AcromegalyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Clinical Endocrinology|September 21, 2006
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical studyMariagiovanna Filippella, Françoise Galland, Michèle Kujas, et al.
Pageof 37

Showing results (161-170 of 363) with videos related to

Sort By:
Pageof 37
Journal of the Endocrine Society|August 7, 2024
Increase in Testosterone Levels and Improvement of Clinical Symptoms in Eugonadic men With a Prolactin-secreting AdenomaLea Carlier, Philippe Chanson, Laure Cazabat, et al.
Endocrine|November 7, 2018
Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literatureClaire Briet, Mirela Diana Ilie, Emmanuelle Kuhn, et al.
Pituitary|July 25, 2019
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation studyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Lancet (London, England)|October 28, 2023
Growing heart in congenital hypopituitarism treated in adulthoodYves Fromes, Fanny Chasseloup, Claire Bouvattier, et al.
Endocrine|April 14, 2021
Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomasOrsalia Alexopoulou, Valérie Everard, Martine Etoa, et al.
European Journal of Endocrinology|December 10, 2016
Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysisNicholas A Tritos, Philippe Chanson, Camilo Jimenez, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegalyLuigi Maione, Cyril Garcia, Amir Bouchachi, et al.
Frontiers in Endocrinology|December 18, 2018
Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome InstabilityAnne Wierinckx, Etienne Delgrange, Philippe Bertolino, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2021
International Multicenter Validation Study of the SAGIT® Instrument in AcromegalyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Clinical Endocrinology|September 21, 2006
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical studyMariagiovanna Filippella, Françoise Galland, Michèle Kujas, et al.
Pageof 37